Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | SOD1 | P00441 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TPMT | P51580 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3784461 | 0.94 | TSHR (0.41) | TSHRCYP3A4TP53SOD1MEN1 | |
| SCHEMBL8487167 | 0.87 | TSHR (0.38) | TSHRCYP3A4TP53 | |
| SCHEMBL9910728 | 0.84 | RAPGEF4 (0.34) | TSHRRAPGEF4 | |
| SCHEMBL30253256 | 0.82 | TSHR (0.32) | TSHR | |
| SCHEMBL11257348 | 0.82 | TSHR (0.32) | TSHR | |
| SCHEMBL3786358 | 0.82 | CYP3A4 (0.55) | TSHRCYP3A4TP53ALDH1A1 | |
| SCHEMBL16951388 | 0.82 | TSHR (0.32) | TSHR | |
| SCHEMBL15279054 | 0.82 | RAPGEF4 (0.36) | TSHRRAPGEF4 | |
| SCHEMBL16562812 | 0.78 | CYP1A1 (0.43) | CYP1A2ALDH1A1MAPT | |
| SCHEMBL11909347 | 0.78 | MEN1 (0.37) | CYP3A4TP53MEN1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119352051-A | Method for preparing sulfoxide by electrocatalytic oxidation of thioether with heterogeneous catalyst with high Faraday efficiency | 齐鲁工业大学(山东省科学院) | 2025-01-24 | — | — | CN | disclosed |
| EP-4455126-A1 | LIGHT-MEDIATED AEROBIC OXIDATION METHOD | Ecosynth (BE) | 2024-10-30 | — | — | EP | disclosed |
| US-20240272108-A1 | NANOPARTICLES FOR CHEMIRESISTOR SENSORS | NANOSCENT LTD. (IL) | 2024-08-15 | — | — | US | disclosed |
| WO-2024165619-A1 | LIGHT-MEDIATED AEROBIC OXIDATION METHOD | HG HOLDING B.V. (NL) | 2024-08-15 | — | — | WO | disclosed |
| WO-2024044493-A2 | TREATMENT OF REPEAT EXPANSION DISEASE | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-02-29 | — | — | WO | disclosed |
| CN-117486662-A | Method for synthesizing sulfoxide compound by heterogeneous catalysis | 成都理工大学 | 2024-02-02 | — | — | CN | disclosed |
| WO-2023156402-A1 | PESTICIDALLY ACTIVE THIOSEMICARBAZONE COMPOUNDS | BASF SE (DE) | 2023-08-24 | — | — | WO | disclosed |
| US-20230212119-A1 | N,N-DIMETHYLTRYPTAMINE AND RELATED PSYCHEDELICS AND USES THEREOF | TERRAN BIOSCIENCES INC. | 2023-07-06 | — | — | US | disclosed |
| WO-2023058028-A1 | NANOPARTICLES FOR CHEMIRESISTOR SENSORS | NANOSCENT LTD. (IL) | 2023-04-13 | — | — | WO | disclosed |
| CN-113651734-B | Method for catalytically oxidizing thioether into sulfone | 成都理工大学 | 2023-02-14 | — | — | CN | disclosed |
| WO-2010031047-A2 | DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL | PLATYPUS TECHNOLOGIES, LLC (US) | 2010-03-18 | — | — | WO | disclosed |
| US-6646165-B2 | Reacting halothiophenol compound with an alkali metal hydroxide to obtain an alkali metal halothiophenolate compound; oxidizing in the presence of a mineral acid to produce bishalophenyl disulfide | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2003-11-11 | — | — | US | disclosed |
| US-20030060665-A1 | Process for producing bishalophenyl disulfide | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2003-03-27 | — | — | US | disclosed |
| EP-1277731-A1 | PROCESS FOR PRODUCING BISHALOPHENYL DISULFIDE | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2003-01-22 | — | — | EP | disclosed |
| EP-0742201-A1 | PROCESS FOR PRODUCING AROMATIC OR HETEROAROMATIC SULFUR COMPOUNDS | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1996-11-13 | — | — | EP | disclosed |
| EP-0034924-B1 | PROCESS FOR PREPARING 3-IODOMETHYL CEPHALOSPORINS | ELI LILLY AND COMPANY (US) | 1984-07-04 | — | — | EP | disclosed |
| US-4337341-A | 4a-Aryl-octahydro-1H-2-pyrindines | ELI LILLY AND COMPANY (US) | 1982-06-29 | — | — | US | disclosed |
| EP-0034924-A2 | Process for preparing 3-iodomethyl cephalosporins | ELI LILLY AND COMPANY (US) | 1981-09-02 | — | — | EP | disclosed |
| US-4266049-A | Process for 3-iodomethyl cephalosporins | ELI LILLY AND COMPANY (US) | 1981-05-05 | — | — | US | disclosed |
| EP-0002937-A1 | Novel pyrindines and their preparation, formulations and use | ELI LILLY AND COMPANY (US) | 1979-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212119-A1 | N,N-DIMETHYLTRYPTAMINE AND RELATED PSYCHEDELICS AND USES THEREOF | PNMT, HTR5A, HNMT | TSHR 3083/4885CYP3A4 1244/4885TP53 4713/4885 |
| US-20030060665-A1 | Process for producing bishalophenyl disulfide | MPST, TST, GRHPR | TSHR 1496/4885CYP3A4 83/4885TP53 2507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.